$PMDI
PSYCHEMEDICS CORP

2015 Q1 Form 10-Q Financial Statement

#000114420415026791 Filed on May 01, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $6.756M $7.045M
YoY Change -4.1% 9.53%
Cost Of Revenue $3.417M $3.249M
YoY Change 5.17% 10.32%
Gross Profit $3.339M $3.796M
YoY Change -12.04% 8.86%
Gross Profit Margin 49.42% 53.88%
Selling, General & Admin $2.433M $2.283M
YoY Change 6.56% 7.66%
% of Gross Profit 72.85% 60.14%
Research & Development $455.8K $345.0K
YoY Change 32.12% 109.45%
% of Gross Profit 13.65% 9.09%
Depreciation & Amortization $343.1K $218.0K
YoY Change 57.38% 5.3%
% of Gross Profit 10.28% 5.74%
Operating Expenses $2.888M $2.628M
YoY Change 9.92% 15.0%
Operating Profit $451.0K $1.168M
YoY Change -61.39% -2.83%
Interest Expense $33.33K $252.00
YoY Change 13125.0% -99.72%
% of Operating Profit 7.39% 0.02%
Other Income/Expense, Net -$33.33K $1.549K
YoY Change -2251.52%
Pretax Income $417.2K $1.170M
YoY Change -64.33% -9.33%
Income Tax $139.7K $413.4K
% Of Pretax Income 33.48% 35.35%
Net Earnings $278.0K $756.0K
YoY Change -63.23% -8.03%
Net Earnings / Revenue 4.11% 10.73%
Basic Earnings Per Share $0.05 $0.14
Diluted Earnings Per Share $0.05 $0.14
COMMON SHARES
Basic Shares Outstanding 5.375M shares 5.318M shares
Diluted Shares Outstanding 5.402M shares 5.371M shares

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.750M $2.210M
YoY Change 24.43% -11.95%
Cash & Equivalents $2.746M $2.209M
Short-Term Investments
Other Short-Term Assets $1.460M $1.520M
YoY Change -3.95% 20.63%
Inventory
Prepaid Expenses
Receivables $4.490M $4.819M
Other Receivables $830.0K $210.0K
Total Short-Term Assets $9.520M $8.759M
YoY Change 8.69% -2.57%
LONG-TERM ASSETS
Property, Plant & Equipment $12.65M $8.593M
YoY Change 47.21% 98.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $740.0K $672.1K
YoY Change 10.1% 76.87%
Total Long-Term Assets $13.40M $9.266M
YoY Change 44.62% 96.3%
TOTAL ASSETS
Total Short-Term Assets $9.520M $8.759M
Total Long-Term Assets $13.40M $9.266M
Total Assets $22.92M $18.02M
YoY Change 27.16% 31.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $470.0K $778.5K
YoY Change -39.63% 3.81%
Accrued Expenses $1.280M $2.444M
YoY Change -47.62% 217.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M $210.6K
YoY Change 564.77%
Total Short-Term Liabilities $3.157M $3.433M
YoY Change -8.04% 124.37%
LONG-TERM LIABILITIES
Long-Term Debt $4.498M $842.4K
YoY Change 434.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.498M $842.4K
YoY Change 434.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.157M $3.433M
Total Long-Term Liabilities $4.498M $842.4K
Total Liabilities $10.45M $5.589M
YoY Change 86.99% 138.86%
SHAREHOLDERS EQUITY
Retained Earnings -$7.095M -$6.602M
YoY Change 7.47%
Common Stock $29.64M $29.12M
YoY Change 1.81%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M
YoY Change 0.0%
Treasury Stock Shares 668.1K shares 668.1K shares
Shareholders Equity $12.47M $12.43M
YoY Change
Total Liabilities & Shareholders Equity $22.92M $18.02M
YoY Change 27.16% 31.47%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income $278.0K $756.0K
YoY Change -63.23% -8.03%
Depreciation, Depletion And Amortization $343.1K $218.0K
YoY Change 57.38% 5.3%
Cash From Operating Activities $470.0K -$260.0K
YoY Change -280.77% -142.62%
INVESTING ACTIVITIES
Capital Expenditures $128.1K $1.524M
YoY Change -91.6% 899.56%
Acquisitions
YoY Change
Other Investing Activities $10.00K -$130.0K
YoY Change -107.69% 225.0%
Cash From Investing Activities -$180.0K -$1.810M
YoY Change -90.06% 376.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $350.0K $0.00
YoY Change
Cash From Financing Activities -1.160M 300.0K
YoY Change -486.67% -137.97%
NET CHANGE
Cash From Operating Activities 470.0K -260.0K
Cash From Investing Activities -180.0K -1.810M
Cash From Financing Activities -1.160M 300.0K
Net Change In Cash -870.0K -1.770M
YoY Change -50.85% 216.07%
FREE CASH FLOW
Cash From Operating Activities $470.0K -$260.0K
Capital Expenditures $128.1K $1.524M
Free Cash Flow $341.9K -$1.784M
YoY Change -119.16% -490.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7094632 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6565894 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3612153 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4078133 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
689995 USD
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1819743 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
376529 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
10576553 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12740131 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
761025 USD
CY2014Q4 us-gaap Assets
Assets
24077709 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
845071 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1351333 USD
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1399925 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1399925 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3156707 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3596329 USD
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4498177 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4848158 USD
CY2015Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2796666 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2796666 USD
CY2015Q1 us-gaap Liabilities
Liabilities
10451550 USD
CY2014Q4 us-gaap Liabilities
Liabilities
11241153 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
30216 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
30216 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29614253 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29454023 USD
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
12468048 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
12836556 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22919598 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24077709 USD
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
74557 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
95525 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6043191 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6043191 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2014Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7044821 USD
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
6755741 USD
CY2014Q1 us-gaap Cost Of Services
CostOfServices
3249039 USD
CY2015Q1 us-gaap Cost Of Services
CostOfServices
3416873 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
3795782 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
3338868 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1184147 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1144090 USD
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1098600 USD
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1288481 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
344983 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
455782 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
2627730 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
2888353 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1168052 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
450515 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1549 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33327 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1169601 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
417188 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413442 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
139666 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
756159 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
277522 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5317836 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5375061 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5371418 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5401998 shares
CY2015Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
404560 shares
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
1050 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
1400 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
1400 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
1400 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
648 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5898 USD
CY2015Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1400 USD
CY2015Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0217 pure
CY2015Q1 us-gaap Interest Expense
InterestExpense
33327 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
218019 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
343115 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
58608 USD
CY2015Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
62089 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
152008 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
160230 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
449799 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
411733 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
55710 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-661832 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
267998 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-426108 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1088173 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-69504 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-258106 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
473265 USD
CY2015Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
66981 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1524432 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
128053 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1806071 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-183575 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
302453 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1156241 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
33201 USD
CY2014Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
1083948 USD
CY2015Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
55990 USD
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000806517
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Trading Symbol
TradingSymbol
PMD
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5376691 shares
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6125058 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5788551 USD
CY2014Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
134447 USD
CY2015Q1 us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
62143 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47564 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1052943 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
349981 USD
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
53000 shares
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
27000 shares
CY2014Q1 pmd Write Off Capitalized Patent Costs
WriteOffCapitalizedPatentCosts
0 USD
CY2015Q1 pmd Write Off Capitalized Patent Costs
WriteOffCapitalizedPatentCosts
73602 USD

Files In Submission

Name View Source Status
0001144204-15-026791-index-headers.html Edgar Link pending
0001144204-15-026791-index.html Edgar Link pending
0001144204-15-026791.txt Edgar Link pending
0001144204-15-026791-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pmd-20150331.xml Edgar Link completed
pmd-20150331.xsd Edgar Link pending
pmd-20150331_cal.xml Edgar Link unprocessable
pmd-20150331_def.xml Edgar Link unprocessable
pmd-20150331_lab.xml Edgar Link unprocessable
pmd-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v407666_10q.htm Edgar Link pending
v407666_ex31-1.htm Edgar Link pending
v407666_ex31-2.htm Edgar Link pending
v407666_ex32-1.htm Edgar Link pending
v407666_ex32-2.htm Edgar Link pending